News Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Jul 16, 2020BEDFORD, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products...
- Jun 2, 2020Sylvia Cheung to Step Down in August 2020
BEDFORD, Mass., June 02, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products across the...
-
May 12, 2020
BEDFORD, Mass.--(BUSINESS WIRE)--May 12, 2020-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company, today announced that Cheryl R....
-
May 7, 2020Total Revenue Increases 43% Year-over-Year
BEDFORD, Mass., May 07, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company, today reported financial...
-
Apr 27, 2020Seasoned industry executive with experience leading global joint preservation and restoration businesses
BEDFORD, Mass.--(BUSINESS WIRE)--Apr. 27, 2020-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
-
Apr 23, 2020
BEDFORD, Mass.--(BUSINESS WIRE)--Apr. 23, 2020-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its first quarter 2020 financial results after the close of...
- Apr 8, 2020
BEDFORD, Mass., April 08, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
-
Mar 4, 2020Seasoned executive brings extensive experience leading corporate legal and governance teams
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary...
- Feb 20, 2020Total Revenue Increases 10% Year-over-Year for the Fourth Quarter
BEDFORD, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
- Feb 12, 2020
BEDFORD, Mass., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that Dr. Cheryl Blanchard, a member of the Company’s Board of Directors since August...
-
Feb 6, 2020
BEDFORD, Mass.--(BUSINESS WIRE)--Feb. 6, 2020-- First paragraph, first sentence should read: Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its...
- Feb 3, 2020Transaction Accelerates Anika’s Revenue Growth, Broadens Joint Preservation and Restoration Product Portfolio, Enhances Commercial Capabilities and Expands Pipeline
BEDFORD, Mass., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
- Jan 29, 2020
BEDFORD, Mass., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK) announced today with great sadness that Joseph Darling, its President and Chief Executive Officer, passed...
Jan 24, 2020Transaction Accelerates Anika’s Revenue Growth, Broadens Joint Preservation and Restoration Product Portfolio, Enhances Commercial Capabilities and Expands PipelineBEDFORD, Mass., Jan. 24, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
-
Jan 6, 2020Accelerates Revenue Growth through Broadened Joint Preservation and Restoration Product Portfolio, Enhances Commercial Capabilities, and Expands Pipeline
BEDFORD, Mass.--(BUSINESS WIRE)--Jan. 6, 2020-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
-
Dec 10, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Dec. 10, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
-
Nov 15, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Nov. 15, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
-
Nov 5, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Nov. 5, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
-
Oct 24, 2019Total Revenue Increases 11% and Net Income Increases 21% Year-over-Year
BEDFORD, Mass.--(BUSINESS WIRE)--Oct. 24, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
-
Oct 16, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Oct. 16, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
-
Oct 14, 2019Industry veteran brings extensive experience leading global regulatory, quality, and clinical affairs teams
BEDFORD, Mass.--(BUSINESS WIRE)--Oct. 14, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated company, focused on developing regenerative therapies leveraging its proprietary...
-
Oct 10, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Oct. 10, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its third-quarter 2019 financial results after the close of...
-
Oct 4, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Oct. 4, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated regenerative therapies company leveraging its proprietary hyaluronic acid ("HA")...
-
Sep 18, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Sep. 18, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company leveraging its proprietary hyaluronic acid ("HA")...
-
Sep 4, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Sep. 4, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary...